Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

C4X Discovery shares up as signs USD400 million deal with AstraZeneca

28th Nov 2022 08:49

(Alliance News) - C4X Discovery Holdings PLC on Monday said it signed an exclusive worldwide licensing agreement with AstraZeneca PLC for its NRF2 Activator programme. Read More

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

15th Nov 2022 09:58

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

TOP NEWS: AstraZeneca receives three recommendations for EU approval

14th Nov 2022 09:38

(Alliance News) - AstraZeneca PLC on Monday said in won three recommendations for approval for the treatment of adults with cancers in the European Union from the Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

14th Nov 2022 09:25

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

LONDON MARKET OPEN: Informa lifts FTSE 100; pound above USD1.18

14th Nov 2022 08:58

(Alliance News) - Stocks in London were mostly lower on Monday, though the FTSE 100 was in the green as investors looked ahead to the UK budget statement later in the week, which Chancellor Jeremy Hunt promised to be "rabbit-free". Read More

TOP NEWS: AstraZeneca wins US FDA approval for lung cancer drugs

11th Nov 2022 09:12

(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration has approved its cancer drugs Imfinzi and Imjudo in combination with chemotherapy for the treatment of adults with stage four non-small cell lung cancer. Read More

TOP NEWS: AstraZeneca swings to third-quarter profit and ups guidance

10th Nov 2022 10:48

(Alliance News) - AstraZeneca PLC on Thursday said it was continuing to see the benefit of sustained investment, as it raised its annual guidance on the back of strong results in the year to date. Read More

LONDON MARKET OPEN: Centrica helps FTSE 100 outperform ahead of US CPI

10th Nov 2022 08:53

(Alliance News) - Stocks in Europe struggled early on Thursday, though the FTSE 100 notched a minor gain, as investors held their breath ahead of all-important inflation data from the world's largest economy. Read More

LONDON BRIEFING: AstraZeneca and Haleon lift annual guidance

10th Nov 2022 07:58

(Alliance News) - Stocks in London are called lower on Thursday, with a stack of UK corporate updates keeping investors busy until the afternoon's eagerly-anticipated US inflation reading. Read More

AstraZeneca celebrates asthma treatment recommendation by US FDA

9th Nov 2022 09:53

(Alliance News) - AstraZeneca PLC on Wednesday said it is well-placed to transform current asthma emergency treatment approaches, after its inhaler was recommended by the US Food & Drug Administration. Read More

IN BRIEF: Beximco Pharmaceuticals revenue up thanks to domestic sales

8th Nov 2022 13:00

Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active pharmaceutical ingredients maker - In the financial year that ended June 30, books pretax profit of BDT6.69 billion, around GBP57.6 million, up 4.9% from BDT6.37 billion a year before. Annual revenue climbs 18% to BDT34.67 billion from BDT29.49 billion, with domestic sales rising by 21% and export sales by 14%. Declares BDT3.5 per share dividend. Read More

FTSE 100 Latest

Value9,095.73

Change-5.04